Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://lilytmnn037944.blog4youth.com/39550754/retaglutide-a-promising-glp-1-receptor-agonist